Eric Joseph
Biotech Analyst,
JP Morgan
Eric Joseph is an Executive Director and Senior Equity Research Analyst covering the Small/Mid-Cap Biotechnology sector at J.P. Morgan. Since joining the firm as an associate in 2014, he’s played a central role within its SMid-Cap Biotech franchise, contributing to runner-up firm rankings in the Institutional Investor survey on multiple occasions. Prior to J.P. Morgan, Eric covered Biotech as a supporting analyst at JMP Securities. Eric earned his PhD at Weill Cornell Medicine in partnership with the Sloan-Kettering Institute and his Honors BSc in Biochemistry at Queen’s University.
Suffix
PhD
Sessions
-
10-Feb-2025AstorVoices from the IPO Class of 2024: What's Next?
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}